When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...

Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating ...

This was the ADR's second consecutive day of losses.

AstraZeneca invests Rs 166 crore in a new Bengaluru Global Hub focused on AI-driven healthcare solutions, creating 400 new ...

AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest ...

AstraZeneca Vietnam held seminars in Hanoi and Ho Chi Minh City to improve hereditary cancer care from June 14-21.

The findings come from the global, multicenter, open-label, and single-arm Phase I/II SYRUS clinical trial (NCT06137118), ...

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...